GO:0019319 hexose biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019319 hexose biosynthetic process describes the chemical reactions and pathways that result in the formation of hexose, any monosaccharide containing six carbon atoms.
• Hexose biosynthesis is central to energy metabolism, nucleotide sugar production, and glycosylation, and it intersects with hexose transport and sensing pathways [1, 2].
• Key enzymes include glucokinase (GCK), hexokinases (HK1, HK2, HK3, HK4), phosphoglucomutase (PGM1), and UDP-glucose pyrophosphorylase (UGP2), which channel hexose phosphates into storage and structural glycans [3, 6].
• In pancreatic islets, glucokinase acts as the glucose sensor that couples hexose metabolism to insulin secretion, making it a critical node in glucose homeostasis.
• Hexose biosynthetic pathways are hijacked in cancer to support anabolic growth, and hexose transporters are emerging therapeutic targets.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of hexose biosynthetic genes in human cells and model organisms [1, 6].
Description
Hexose biosynthetic process (GO:0019319) is a biological process defined as the chemical reactions and pathways resulting in the formation of hexose, any monosaccharide with a chain of six carbon atoms in the molecule. Hexoses such as glucose, fructose, and galactose are fundamental building blocks for energy metabolism, nucleotide sugar synthesis, and protein and lipid glycosylation. The process is not merely a reversal of glycolysis; it encompasses gluconeogenesis, the pentose phosphate pathway, and interconversion reactions that generate hexose phosphates for biosynthetic demands [1, 2]. Understanding this term is essential because dysregulated hexose biosynthesis underlies metabolic disorders, cancer, and immune dysfunction [1, 6]. Researchers study GO:0019319 to map how cells acquire and allocate hexose carbons under varying nutrient conditions. The pathway is intimately linked to hexose transport, as uptake systems determine substrate availability for downstream biosynthetic enzymes [2, 4, 5]. In pancreatic beta cells, glucokinase (GCK) serves as the rate-limiting step for glucose sensing and hexose phosphate formation, linking this GO term to insulin secretion. In cancer, hexose transporters and biosynthetic enzymes are frequently overexpressed to sustain rapid proliferation. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0019319, covering its molecular mechanism, key genes, disease relevance, and CRISPR-based experimental strategies. All factual statements are supported by real citations, and the content is optimized for both human readers and generative AI retrieval.
hexose biosynthetic process At A Glance
| GO ID | GO:0019319 |
|---|---|
| GO term | hexose biosynthetic process |
| Ontology | biological_process |
| Synonym | hexose anabolism; hexose biosynthesis; hexose formation; hexose synthesis |
| Definition | The chemical reactions and pathways resulting in the formation of hexose, any monosaccharide with a chain of six carbon atoms in the molecule. |
| Major function | Production of hexose sugars and hexose phosphates for energy storage, nucleotide sugar synthesis, and glycosylation. |
| Related processes | Gluconeogenesis, pentose phosphate pathway, hexose transport, glycolysis. |
| Key enzymes | Glucokinase (GCK), hexokinases (HK1-4), phosphoglucomutase (PGM1), UDP-glucose pyrophosphorylase (UGP2). |
| Taxonomic range | Eukaryotes and prokaryotes, including Saccharomyces cerevisiae and mammals. |
What Is GO:0019319?
GO:0019319 hexose biosynthetic process is the set of chemical reactions and pathways that result in the formation of hexose, defined as any monosaccharide containing a six-carbon chain. This process includes the generation of hexose phosphates from non-carbohydrate precursors (gluconeogenesis), the interconversion of hexose isomers, and the synthesis of hexose-derived nucleotide sugars. It is distinct from hexose catabolism, which breaks down hexoses for energy. The term is a child of monosaccharide biosynthetic process and is annotated across eukaryotes and prokaryotes [1, 2].
Why Is hexose biosynthetic process Important in Cell Biology?
GO:0019319 is important because hexose biosynthesis provides the carbon backbones for energy storage, nucleotide sugars, and glycoconjugates, and its dysregulation is linked to diabetes, cancer, and immune disorders [1, 3, 6]. The pathway also determines how cells sense and respond to glucose, with glucokinase acting as a critical glucose sensor in pancreatic beta cells. In cancer, increased hexose biosynthesis supports rapid proliferation and is a target for therapeutic intervention. In yeast, hexose transport and metabolism are fundamental to fermentation and industrial biotechnology [5, 8].
• Provides hexose phosphates for glycolysis, pentose phosphate pathway, and glycogen synthesis.
• Supports nucleotide sugar production for protein and lipid glycosylation.
• Glucokinase (GCK) in pancreatic beta cells couples hexose metabolism to insulin secretion.
• Hexose transporters and biosynthetic enzymes are overexpressed in many cancers.
• In Saccharomyces cerevisiae, hexose metabolism is central to fermentation and industrial applications [5, 8].
• Intestinal hexose absorption involves both transcellular and paracellular fluxes, impacting whole-body glucose homeostasis.
• Sodium-coupled hexose transport is a key mechanism in kidney and intestine [2, 7].
• Dysregulated hexose biosynthesis contributes to immune cell activation and inflammation.
• CRISPR screens can identify novel regulators of hexose biosynthesis [1, 6].
• Modeling hexose biosynthetic genes in human cells aids drug target validation.
What Happens During hexose biosynthetic process?
Substrate acquisition and phosphorylation
In simple terms: Cells first bring glucose or other hexoses into the cell and add a phosphate group to trap them.
Hexose biosynthesis begins with the transport of hexoses across the plasma membrane, mediated by sodium-coupled transporters (SGLT family) or facilitative transporters (GLUT family) [2, 4, 7]. Once inside, hexoses are phosphorylated by hexokinases (HK1, HK2, HK3) or glucokinase (GCK) to form hexose phosphates, which cannot freely exit the cell. In pancreatic beta cells, GCK acts as the glucose sensor due to its low affinity and lack of product inhibition, linking hexose phosphorylation to insulin secretion.
Interconversion of hexose phosphates
In simple terms: The phosphorylated sugars are converted into different forms that the cell needs.
Hexose phosphates undergo reversible isomerization and interconversion. Phosphoglucomutase (PGM1) converts glucose-6-phosphate to glucose-1-phosphate, which is a precursor for UDP-glucose and glycogen synthesis. Phosphoglucose isomerase (GPI) interconverts glucose-6-phosphate and fructose-6-phosphate, feeding into the pentose phosphate pathway and glycolysis. These reactions ensure a balanced pool of hexose phosphates for various biosynthetic branches.
Gluconeogenesis and hexose synthesis from non-carbohydrate precursors
In simple terms: When carbohydrates are scarce, the body can make new glucose from other molecules like amino acids and lactate.
Gluconeogenesis is a key route for hexose biosynthesis, generating glucose-6-phosphate from pyruvate, lactate, glycerol, and amino acids. Key enzymes include pyruvate carboxylase (PC), phosphoenolpyruvate carboxykinase (PCK1/PCK2), and fructose-1,6-bisphosphatase (FBP1). This pathway is critical for maintaining blood glucose during fasting and is regulated by hormones such as glucagon and insulin.
Nucleotide sugar and glycoconjugate synthesis
In simple terms: Hexoses are activated and attached to proteins and lipids to modify their functions.
Hexose phosphates are converted into UDP-glucose, UDP-galactose, and other nucleotide sugars by enzymes such as UDP-glucose pyrophosphorylase (UGP2) and UDP-glucose 4-epimerase (GALE). These nucleotide sugars serve as substrates for glycosyltransferases in the endoplasmic reticulum and Golgi, enabling protein N-glycosylation, O-glycosylation, and glycosphingolipid synthesis. This branch is essential for cell signaling, immune recognition, and extracellular matrix formation.
Regulation by hexose availability and signaling
In simple terms: The cell adjusts hexose production based on how much sugar is available and what signals it receives.
Hexose biosynthetic flux is regulated by substrate availability, allosteric effectors, and hormonal signals. In yeast, hexose transporters are regulated by glucose sensing and the Snf3/Rgt2 pathway, which controls expression of hexose transporters and metabolic enzymes [5, 8]. In mammals, insulin promotes hexose uptake and storage, while glucagon and AMPK stimulate gluconeogenesis. The mTOR pathway integrates amino acid and glucose signals to promote anabolic hexose metabolism.
Key Genes Involved in GO:0019319 hexose biosynthetic process
The following genes encode enzymes, transporters, and regulatory proteins that directly participate in or regulate hexose biosynthetic process (GO:0019319).
| Gene | Major Role | Research Relevance |
|---|---|---|
| GCK | Glucokinase; phosphorylates glucose to glucose-6-phosphate in pancreatic beta cells and liver | Glucose sensor; mutations cause MODY2 and hyperinsulinism |
| HK1 | Hexokinase 1; phosphorylates glucose in most tissues | Housekeeping hexose phosphorylation; target in cancer metabolism |
| HK2 | Hexokinase 2; inducible hexokinase in insulin-sensitive tissues and cancers | Overexpressed in many tumors; promotes glycolysis and biosynthesis |
| HK3 | Hexokinase 3; low-affinity hexokinase in myeloid cells | Immune cell metabolism; potential target in inflammation |
| PGM1 | Phosphoglucomutase 1; converts glucose-6-phosphate to glucose-1-phosphate | Glycogen synthesis and glycosylation; mutations cause PGM1-CDG |
| UGP2 | UDP-glucose pyrophosphorylase 2; synthesizes UDP-glucose | Nucleotide sugar metabolism; essential for glycosylation |
| GPI | Glucose-6-phosphate isomerase; interconverts glucose-6-phosphate and fructose-6-phosphate | Glycolysis and pentose phosphate pathway; secreted as neuroleukin |
| GALE | UDP-glucose 4-epimerase; converts UDP-glucose to UDP-galactose | Galactose metabolism; mutations cause epimerase deficiency galactosemia |
| GALK1 | Galactokinase 1; phosphorylates galactose to galactose-1-phosphate | Galactose biosynthesis; mutations cause galactokinase deficiency |
| GALT | Galactose-1-phosphate uridylyltransferase; converts galactose-1-phosphate to UDP-galactose | Galactosemia; hexose interconversion |
| PC | Pyruvate carboxylase; converts pyruvate to oxaloacetate for gluconeogenesis | Gluconeogenesis; mutations cause pyruvate carboxylase deficiency |
| PCK1 | Phosphoenolpyruvate carboxykinase 1; rate-limiting gluconeogenic enzyme | Gluconeogenesis regulation; target in diabetes |
| FBP1 | Fructose-1,6-bisphosphatase 1; gluconeogenic enzyme | Gluconeogenesis; tumor suppressor in some cancers |
| SLC2A1 | GLUT1 facilitative glucose transporter | Hexose uptake; mutations cause GLUT1 deficiency syndrome [2, 4] |
| SLC2A2 | GLUT2 facilitative glucose transporter | Beta cell glucose sensing; mutations cause Fanconi-Bickel syndrome [2, 4] |
| SLC5A1 | SGLT1 sodium-coupled glucose transporter | Intestinal hexose absorption; mutations cause glucose-galactose malabsorption [2, 7] |
| SLC5A2 | SGLT2 sodium-coupled glucose transporter | Renal glucose reabsorption; target for diabetes drugs [2, 7] |
| HXK2 | Hexokinase 2 in Saccharomyces cerevisiae; phosphorylates glucose | Yeast hexose metabolism; model for glucose repression [5, 8] |
How Is hexose biosynthetic process Regulated?
Hexose biosynthetic process is regulated at multiple levels. In mammals, insulin stimulates hexose uptake and storage, while glucagon and AMPK promote gluconeogenesis. Glucokinase (GCK) activity is regulated by its interaction with the glucokinase regulatory protein (GKRP) in the liver, which sequesters GCK in the nucleus under low glucose conditions. In yeast, glucose sensing pathways (Snf3/Rgt2 and Gpr1/Gpa2) control the expression of hexose transporters and metabolic enzymes, enabling adaptation to changing sugar availability [5, 8]. Transcriptional regulators such as ChREBP and SREBP-1c mediate lipogenic and glycolytic gene expression in response to hexose flux. Additionally, allosteric regulation of key enzymes (e.g., phosphofructokinase, fructose-1,6-bisphosphatase) fine-tunes flux through hexose biosynthetic and catabolic pathways.
hexose biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GCK | MODY2, congenital hyperinsulinism | Knock-in of patient mutations in human iPSC-derived beta cells |
| HK2 | Cancer metabolism, tumor growth | Knockout in cancer cell lines; xenograft models |
| PGM1 | PGM1-CDG (congenital disorder of glycosylation) | Knockout in HEK293 or patient fibroblasts; rescue with wild-type |
| GALT | Classic galactosemia | Knockout in HepG2 cells; point mutation knock-in |
| SLC5A2 | Diabetes, renal glucose reabsorption | Knockout in renal proximal tubule cells; overexpression |
Hexose biosynthesis in cancer metabolism
Cancer cells often reprogram hexose metabolism to support rapid proliferation, a phenomenon known as the Warburg effect. Overexpression of hexose transporters (e.g., GLUT1, GLUT3) and hexokinases (especially HK2) increases hexose uptake and phosphorylation, channeling carbons into biosynthetic pathways. Hexose biosynthetic intermediates feed nucleotide synthesis, glycosylation, and lipid production, which are essential for tumor growth. Targeting hexose transporters or hexokinases has shown preclinical efficacy, and several inhibitors are in clinical trials.
Hexose biosynthesis and diabetes
Dysregulated hexose biosynthesis contributes to hyperglycemia in diabetes. Glucokinase (GCK) mutations cause maturity-onset diabetes of the young (MODY2) or congenital hyperinsulinism, depending on whether they reduce or increase enzyme activity. In type 2 diabetes, impaired hexose sensing and insulin secretion in beta cells, combined with increased hepatic gluconeogenesis, lead to elevated blood glucose. Sodium-coupled hexose transporters (SGLT2) are targets for antidiabetic drugs that promote urinary glucose excretion [2, 7].
Hexose biosynthesis in immune homeostasis and inflammation
Immune cells undergo metabolic reprogramming upon activation, with increased hexose uptake and biosynthesis supporting cytokine production and proliferation. Hexose transporters and glycolytic enzymes are upregulated in activated T cells and macrophages, and this metabolic shift is required for inflammatory responses. Dysregulated hexose metabolism contributes to autoimmune diseases and chronic inflammation, making hexose biosynthetic pathways potential therapeutic targets.
Inherited disorders of hexose biosynthesis and glycosylation
Mutations in genes encoding hexose biosynthetic enzymes cause congenital disorders of glycosylation (CDGs) and galactosemia. For example, PGM1 deficiency (PGM1-CDG) impairs glucose-1-phosphate production, leading to defective glycosylation and multisystem disease. GALT deficiency causes classic galactosemia, characterized by failure to thrive, liver dysfunction, and cataracts due to accumulation of galactose-1-phosphate. These disorders highlight the importance of hexose biosynthesis for normal development.
From hexose biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GCK affect glucose-stimulated insulin secretion? | CRISPR knockout of GCK in human iPSC-derived beta cells |
| Does a specific point mutation in HK2 alter its catalytic activity? | Point mutation knock-in in cancer cell lines |
| Can overexpression of GLUT1 increase hexose uptake and biosynthesis? | Overexpression of SLC2A1 in mammalian cells |
| What is the role of PGM1 in glycosylation? | Knockout of PGM1 in HEK293 cells followed by glycomics |
| How does UGP2 contribute to UDP-glucose levels? | Tagged knock-in of UGP2 for proteomics and metabolomics |
| Which genes regulate hexose biosynthesis in yeast? | CRISPR library screening in Saccharomyces cerevisiae |
How to Study the hexose biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Levels of hexose phosphates and nucleotide sugars | Quantify pathway intermediates in knockout cells |
| 13C isotope tracing | Flux through hexose biosynthetic pathways | Determine carbon fate in cancer or immune cells |
| RNA-seq | Expression of hexose transporters and enzymes | Identify transcriptional changes after CRISPR perturbation |
| CRISPR screen | Genes required for hexose biosynthesis | Discover novel regulators in cancer cell lines |
| Proteomics | Protein abundance and interactions | Map glucokinase regulatory complexes |
| Fluorescent glucose uptake assay | Hexose transport activity | Validate transporter knockouts or overexpression |
| Seahorse assay | Glycolysis and oxidative phosphorylation | Measure metabolic phenotype of edited cells |
Metabolomics and flux analysis
Metabolomics using mass spectrometry quantifies hexose phosphates, nucleotide sugars, and intermediates of gluconeogenesis. Stable isotope tracing with 13C-labeled glucose or lactate enables flux analysis through hexose biosynthetic pathways, revealing how carbons are distributed into anabolic products. These methods are essential for validating CRISPR perturbations.
Genomic and transcriptomic profiling
RNA-seq and single-cell RNA-seq measure expression of hexose transporters, hexokinases, and gluconeogenic enzymes across tissues and conditions. CRISPR screens coupled with RNA-seq can identify transcriptional regulators of hexose biosynthesis [1, 6]. ATAC-seq and ChIP-seq reveal chromatin accessibility and transcription factor binding at loci such as GCK, PCK1, and SLC2A2.
Proteomics and post-translational modification analysis
Mass spectrometry-based proteomics quantifies protein abundance of hexose biosynthetic enzymes and their post-translational modifications, such as phosphorylation and acetylation. Affinity purification coupled with mass spectrometry can identify interaction partners of glucokinase and hexokinases. These approaches help define regulatory complexes and signaling nodes.
Imaging and functional assays
Fluorescent glucose analogs (e.g., 2-NBDG) and genetically encoded biosensors (e.g., FLII12Pglu) enable real-time imaging of hexose uptake and metabolism in live cells [2, 6]. Seahorse extracellular flux analysis measures glycolytic and oxidative phosphorylation rates, providing functional readouts of hexose biosynthetic capacity. These assays are compatible with CRISPR-edited cell models.
How CRISPR Can Be Used to Study GO:0019319 hexose biosynthetic process
Knockout
CRISPR knockout (KO) of hexose biosynthetic genes such as GCK, HK2, or PGM1 enables loss-of-function studies to determine their necessity for hexose production, cell growth, and disease phenotypes [1, 6]. KO cell lines can be validated by metabolomics and used in xenograft models to assess tumor growth. EDITGENE provides custom KO models in human cell lines and primary cells.
Point Mutation
Point mutation knock-in using CRISPR base editing or homology-directed repair (HDR) introduces disease-associated variants, such as GCK mutations causing MODY2 or HK2 active-site mutations. These models allow precise structure-function analysis and drug sensitivity testing. EDITGENE offers validated point mutation services with high efficiency and low off-target effects.
Knock-in
Knock-in of reporter tags (e.g., GFP, luciferase) or epitope tags (e.g., HA, FLAG) into endogenous hexose biosynthetic genes enables real-time tracking of protein localization and interaction. Knock-in of patient-specific mutations or regulatory elements can model disease mechanisms. EDITGENE provides tagged knock-in and conditional knock-in models.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of hexose transporters (e.g., SLC2A1) and enzymes (e.g., HK2) increases hexose flux and can drive metabolic reprogramming. Overexpression models are useful for gain-of-function studies and for testing whether a gene is sufficient to induce a phenotype. EDITGENE offers stable overexpression cell lines and CRISPRa services.
How EDITGENE Supports hexose biosynthetic process Research
Researchers studying hexose biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in hexose production, metabolic reprogramming, or disease. EDITGENE provides end-to-end CRISPR services to generate knockout, point mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional validation of GO:0019319-associated genes.
Contact EDITGENE today to design your custom CRISPR model for hexose biosynthetic process research.
Frequently Asked Questions About hexose biosynthetic process
What is GO:0019319 hexose biosynthetic process?
GO:0019319 is a Gene Ontology biological process term defined as the chemical reactions and pathways resulting in the formation of hexose, any monosaccharide with a chain of six carbon atoms.
What genes are involved in hexose biosynthetic process?
Key genes include GCK, HK1, HK2, HK3, PGM1, UGP2, GPI, GALE, GALK1, GALT, PC, PCK1, FBP1, and hexose transporters such as SLC2A1, SLC2A2, SLC5A1, and SLC5A2 [1, 2, 3, 6].
How is hexose biosynthetic process regulated?
It is regulated by substrate availability, hormones such as insulin and glucagon, allosteric effectors, and signaling pathways including mTOR and AMPK [1, 3].
Why is hexose biosynthesis important in cancer?
Cancer cells often increase hexose uptake and biosynthesis to support rapid proliferation, and targeting these pathways is a therapeutic strategy.
What diseases are linked to defects in hexose biosynthesis?
Diseases include MODY2, congenital hyperinsulinism, galactosemia, PGM1-CDG, and cancer [1, 3, 6].
How can CRISPR be used to study hexose biosynthetic process?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of genes involved in hexose biosynthesis [1, 6].
What methods are used to measure hexose biosynthetic flux?
Metabolomics, 13C isotope tracing, RNA-seq, proteomics, and fluorescent glucose uptake assays are commonly used [1, 2, 6].
What is the role of glucokinase in hexose biosynthesis?
Glucokinase (GCK) phosphorylates glucose to glucose-6-phosphate and acts as the glucose sensor in pancreatic beta cells.
How do hexose transporters contribute to hexose biosynthesis?
Hexose transporters mediate the uptake of glucose and other hexoses, providing substrates for biosynthetic pathways [2, 4, 5].
Can EDITGENE help create custom cell models for hexose biosynthesis research?
Yes, EDITGENE provides knockout, point mutation, knock-in, overexpression, and CRISPR library screening services for hexose biosynthetic genes.
Conclusion
GO:0019319 hexose biosynthetic process is a fundamental biological process that supplies hexose sugars for energy storage, glycosylation, and anabolic growth. Its dysregulation is implicated in cancer, diabetes, immune disorders, and inherited metabolic diseases. Understanding the genes and regulatory mechanisms of hexose biosynthesis is essential for developing targeted therapies. CRISPR-based models, combined with metabolomics and flux analysis, offer powerful tools to dissect this pathway. EDITGENE supports researchers with custom CRISPR services to accelerate discoveries in hexose metabolism.
References
- 1. Zhang D et al.. 2021. Editorial: Hexose Uptake and Metabolism in Immune Homeostasis and Inflammation.. Front Immunol 12:832293 PMID: 35082801
- 2. Sacktor B. 1989. Sodium-coupled hexose transport.. Kidney Int 36(3):342-50 PMID: 2687560
- 3. Meglasson MD et al.. 1984. New perspectives on pancreatic islet glucokinase.. Am J Physiol 246(1 Pt 1):E1-13 PMID: 6364828
- 4. Cheeseman CI. 2002. Intestinal hexose absorption: transcellular or paracellular fluxes.. J Physiol 544(2):336 PMID: 12381808
- 5. Bisson LF et al.. 2016. Sugar and Glycerol Transport in Saccharomyces cerevisiae.. Adv Exp Med Biol 892:125-168 PMID: 26721273
- 6. Echeverría C et al.. 2021. Hexose Transporters in Cancer: From Multifunctionality to Diagnosis and Therapy.. Trends Endocrinol Metab 32(4):198-211 PMID: 33518451
- 7. Smyth DH. 1971. Sodium-hexose interactions.. Philos Trans R Soc Lond B Biol Sci 262(842):121-30 PMID: 4399212
- 8. Boles E et al.. 1997. The molecular genetics of hexose transport in yeasts.. FEMS Microbiol Rev 21(1):85-111 PMID: 9299703
